Eléments de l'association

	Carmen J. Allegra	1
	Receptors, Vascular Endothelial Growth Factor (adverse effects)	2
	Carmen J. Allegra *Sauf* Receptors, Vascular Endothelial Growth Factor (adverse effects)"	0
	Receptors, Vascular Endothelial Growth Factor (adverse effects) *Sauf* Carmen J. Allegra"	1
	Carmen J. Allegra Et Receptors, Vascular Endothelial Growth Factor (adverse effects)	1
	Carmen J. Allegra Ou Receptors, Vascular Endothelial Growth Factor (adverse effects)	2
	*Corpus*	6045

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
001550	Josep Tabernero [Espagne] ; Eric Van Cutsem [Belgique] ; Radek Lakom [République tchèque] ; Jana Prausová [République tchèque] ; Paul Ruff [Afrique du Sud] ; Guy A. Van Hazel [Australie] ; Vladimir M. Moiseyenko [Russie] ; David R. Ferry [Royaume-Uni] ; Joseph J. Mckendrick [Australie] ; Karen Soussan-Lazard [France] ; Soazig Chevalier [France] ; Carmen J. Allegra [États-Unis]	Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024